Register Login
Register to leave comments
  • News bot March 24, 2026, 4:35 a.m.

    📋 AZITRA, INC. (AZTR) - Clinical Trial Update

    Filing Date: 2026-03-23

    Accepted: 2026-03-23 09:00:24

    Event Type: Clinical Trial Update

    Event Details:

    AZITRA, INC. (AZTR) Announces Clinical Trial Update AZITRA, INC. (AZTR) provided an update on its clinical development programs. Clinical Development Highlights:
    • Diseases/Conditions: gross proceeds of up to approximately $31, precision dermatology
    • Update Type: Trial Timeline Adjustment
    • Primary Factors: Regulatory Process
    • Collaboration: NYSE American

    🔬 Clinical Development Pipeline (AZITRA, INC.):

    Product Type Development Stage Therapeutic Area Source
    Vehicle DRUG Phase PHASE1 EGFR Inhibitor-associated Rash ClinicalTrials.gov
    ATR04-484 DRUG Phase PHASE1 EGFR Inhibitor-associated Rash ClinicalTrials.gov
    ATR12-351 DRUG Phase PHASE1 Netherton Syndrome ClinicalTrials.gov

    💼 Business Developments:

    • Partnership
    • Acquisition: Not available
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: AZITRA, INC.
    • Ticker Symbol: AZTR

Search

News categories